Treatment-resistant depression (TRD) is a subtype of depression where individuals fail to achieve remission following multiple antidepressant therapies. Ketamine is a new and emerging treatment that shows promise in treating TRD. This video discusses how ketamine works and common side effects.
Disclaimer: Ketamine infusion therapy is an experimental treatment that, as of November 2020, is not approved by the FDA. If you are interested in ketamine infusion therapy for TRD, visit your family doctor or psychiatrist to learn more about your eligibility.
- Find a healthcare provider at: www.ontario.ca/locations/health
Find free, confidential online therapy at:
Canada Suicide Prevention Services (available 24/7/365):
- Call 833-456-4566, or text 741741
Learn more about depression and other resources at: